{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:54:06Z","timestamp":1784555646851,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.josat.2025.209764","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:43Z","timestamp":1753891303000},"page":"209764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Retention rates and cost-effectiveness of telehealth vs. in-person buprenorphine treatment for opioid use disorder (OUD)"],"prefix":"10.1016","volume":"177","author":[{"given":"Rana","family":"Saad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa H.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie G.","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal R.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Borrego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2025.209764_bb0005","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2022"},{"issue":"7","key":"10.1016\/j.josat.2025.209764_bb0010","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/10826084.2023.2212378","article-title":"Use of telehealth for opioid use disorder treatment in safety-net primary care settings: A mixed-methods study","volume":"58","author":"Bailey","year":"2023","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2025.209764_bb0015","series-title":"Occupational employment and wage statistics","author":"Bureau of Labor Statistics","year":"2021"},{"key":"10.1016\/j.josat.2025.209764_bb0020","series-title":"Death rate maps & graphs","author":"Centers for Disease Control and Prevention","year":"2022"},{"key":"10.1016\/j.josat.2025.209764_bb0025","unstructured":"Centers for Disease Control and Prevention. (n.d.). Understanding the opioid overdose epidemic. https:\/\/www.cdc.gov\/overdose-prevention\/about\/understanding-the-opioid-overdose-epidemic.html."},{"key":"10.1016\/j.josat.2025.209764_bb0030","author":"Centers for Medicare & Medicaid Services"},{"key":"10.1016\/j.josat.2025.209764_bb0035","article-title":"Patient satisfaction with medications for opioid use disorder treatment via telemedicine: Brief literature review and development of a new assessment","volume":"8","author":"Cole","year":"2020","journal-title":"Frontiers in Public Health"},{"key":"10.1016\/j.josat.2025.209764_bb0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2017.01.048","article-title":"The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting","volume":"176","author":"Eibl","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.josat.2025.209764_bb0045","first-page":"761","article-title":"Utilization of telehealth solutions for patients with opioid use disorder using buprenorphine: A scoping review","volume":"28","author":"Guillen","year":"2022","journal-title":"Telemedicine and e-Health"},{"issue":"S1","key":"10.1016\/j.josat.2025.209764_bb0050","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1046\/j.1440-1819.1998.0520s5S145.x","article-title":"Recovery from psychological trauma","volume":"52","author":"Herman","year":"1998","journal-title":"Psychiatry and Clinical Neurosciences"},{"issue":"5","key":"10.1016\/j.josat.2025.209764_bb0060","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/jrh.12760","article-title":"Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single-arm, multisite feasibility study","volume":"39","author":"Hser","year":"2023","journal-title":"The Journal of Rural Health"},{"issue":"4","key":"10.1016\/j.josat.2025.209764_bb0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/ajad.12921","article-title":"Sex-based differences in treatment outcomes for persons with opioid use disorder","volume":"28","author":"Huhn","year":"2019","journal-title":"American Journal of Addictions"},{"key":"10.1016\/j.josat.2025.209764_bb0070","series-title":"IBM SPSS Statistics for Windows (version 29.0.2.0) [computer software]","author":"IBM Corp","year":"2023"},{"key":"10.1016\/j.josat.2025.209764_bb0075","author":"Internal Revenue Service"},{"issue":"8","key":"10.1016\/j.josat.2025.209764_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Network Open"},{"issue":"5","key":"10.1016\/j.josat.2025.209764_bb0085","first-page":"439","article-title":"Receipt of telehealth services, receipt and retention of medications for opioid use disorder, and medically treated overdose among Medicare beneficiaries before and during the COVID-19 pandemic","volume":"79","author":"Jones","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2025.209764_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108074","article-title":"Lessons from COVID-19: Are we finally ready to make opioid treatment accessible?","volume":"117","author":"Krawczyk","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209764_bb0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsat.2019.03.007","article-title":"Telemedicine-delivered treatment interventions for substance use disorders: A systematic review","volume":"101","author":"Lin","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209764_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209188","article-title":"Gender differences in receipt of telehealth versus in-person behavioral therapy, medication for opioid use disorder (MOUD), and 90-day MOUD retention during the pandemic: A retrospective veteran cohort study","volume":"156","author":"Livingston","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2025.209764_bb0105","series-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences, Engineering, and Medicine","year":"2019"},{"key":"10.1016\/j.josat.2025.209764_bb0110","author":"National Institute on Drug Abuse"},{"key":"10.1016\/j.josat.2025.209764_bb0115","author":"National Quality Forum"},{"key":"10.1016\/j.josat.2025.209764_bb0120","series-title":"Cost-effectiveness in health and medicine","author":"Neumann","year":"2016"},{"key":"10.1016\/j.josat.2025.209764_bb0125","author":"New Mexico Department of Health"},{"key":"10.1016\/j.josat.2025.209764_bb0130","author":"New Mexico Human Services Department"},{"issue":"3","key":"10.1016\/j.josat.2025.209764_bb0135","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s40501-015-0054-5","article-title":"Gender considerations in addiction: Implications for treatment","volume":"2","author":"Polak","year":"2015","journal-title":"Current Treatment Options in Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2025.209764_bb0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13011-024-00608-8","article-title":"Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: Differences by gender, PTSD status, and chronic pain","volume":"19","author":"Rodr\u00edguez","year":"2024","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"4","key":"10.1016\/j.josat.2025.209764_bb0145","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/ADM.0000000000000685","article-title":"Innovation during COVID-19: Improving addiction treatment access","volume":"14","author":"Samuels","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2025.209764_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209344","article-title":"The lived experiences and treatment needs of women with opioid use disorder and posttraumatic stress symptoms: A mixed methods study","volume":"161","author":"Saraiya","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2025.209764_bb0155","first-page":"1419","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2019","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.josat.2025.209764_bb0160","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.josat.2025.209764_bb0165","series-title":"TIP 63: Medications for opioid use disorder (PEP21-02-01-002)","author":"Substance Abuse and Mental Health Services Administration","year":"2021"},{"key":"10.1016\/j.josat.2025.209764_bb0170","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2025.209764_bb0175","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2025.209764_bb0180","author":"Substance Abuse and Mental Health Services Administration"},{"issue":"1","key":"10.1016\/j.josat.2025.209764_bb0185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.josat.2025.209764_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108124","article-title":"Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine","volume":"118","author":"Uscher-Pines","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2025.209764_bb0195","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00325481.2021.1884471","article-title":"Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder","volume":"133","author":"Velez","year":"2021","journal-title":"Postgraduate Medicine"},{"issue":"1","key":"10.1016\/j.josat.2025.209764_bb0200","doi-asserted-by":"crossref","DOI":"10.1080\/20016689.2021.1966187","article-title":"Cost-effectiveness analysis of a prescription digital therapeutic for the treatment of opioid use disorder","volume":"9","author":"Velez","year":"2021","journal-title":"Journal of Market Access & Health Policy"},{"key":"10.1016\/j.josat.2025.209764_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209310","article-title":"Barriers to retention in medications for opioid use disorder treatment in real-world practice","volume":"160","author":"Villamil","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"12","key":"10.1016\/j.josat.2025.209764_bb0210","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"},{"issue":"8","key":"10.1016\/j.josat.2025.209764_bb0215","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/ajad.12805","article-title":"Expanding access to buprenorphine treatment in rural areas with the use of telemedicine","volume":"27","author":"Weintraub","year":"2018","journal-title":"American Journal on Addictions"},{"issue":"1","key":"10.1016\/j.josat.2025.209764_bb0220","first-page":"5","article-title":"Outcomes for patients receiving telemedicine-delivered medication-based treatment for opioid use disorder: A retrospective chart review","volume":"23","author":"Weintraub","year":"2021","journal-title":"Heroin Addiction and Related Clinical Problems"},{"key":"10.1016\/j.josat.2025.209764_bb0225","article-title":"Implementing a low-threshold audio-only telehealth model for medication-assisted treatment of opioid use disorder at a community-based non-profit organization in Washington, D.C","volume":"18, Article 127","author":"Yeo","year":"2021","journal-title":"Harm Reduction Journal"},{"issue":"2","key":"10.1016\/j.josat.2025.209764_bb0230","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/ADM.0000000000000287","article-title":"Treatment outcome comparison between telepsychiatry and face-to-face buprenorphine medication-assisted treatment for opioid use disorder: A 2-year retrospective data analysis","volume":"11","author":"Zheng","year":"2017","journal-title":"Journal of Addiction Medicine"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T11:35:33Z","timestamp":1755862533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925001432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":45,"alternative-id":["S2949875925001432"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209764","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retention rates and cost-effectiveness of telehealth vs. in-person buprenorphine treatment for opioid use disorder (OUD)","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209764"}}